Objective Handgrip strength (HGS) is a simple, non-invasive measure associated with disability, frailty and disease activity ...

The FDA approved the combination of pembrolizumab (Keytruda) and enfortumab vedotin-ejfv (Padcev) for neoadjuvant and ...

Patients with initially low- or intermediate-risk primary tumors will often have a high-risk recurrence before progressing to more advanced disease, whereas primary high-risk tumors typically show ...

ANDRÉ SILVA The forward continued treatment for a posterior cruciate ligament injury and a strain in the anterior cruciate ...

The addition of atezolizumab to BCG did not yield improved EFS compared with BCG alone in patients with high-risk ...

The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...